EARLY PHASE
DEVELOPMENT SOLUTIONS
Expedited Drug Development
That Maximizes the Value of Your Asset
Accelerate your molecule’s success with a programmatic approach to drug
development, powered by a multi-disciplinary, dedicated team of experts.
Move your program swiftly through critical milestones while maximizing the
value of your asset with an innovative model that can reduce your early drug
development timeline up to 30 percent.
FROM THE VERY BEGINNING YOU GET A PROSPECTIVE
STRATEGY AND DEDICATED TEAM TO ACCELERATE
YOUR JOURNEY TO YOUR DESIRED ENDPOINT.
▶ Continuity of science, regulatory and health economics
▶ Unsurpassed partnership through the drug development journey
▶ Flexible business processes that are aligned to your preferences
START WITH THE END IN MIND TO MAKE
SMARTER DECISIONS—AT EVERY STAGE.
TAKE YOUR MOLECULE FURTHER WITH A TEAM
FOCUSED ON A SINGLE GOAL — YOURS.
CONTINUITY
Save valuable time with a consistent
team and prospective strategy that
delivers integrated efficiency
▶ Expert team led by a Drug Development
Leader that remains with you for the duration
of your drug development journey
▶ Prospective plan that eliminates white space
and unifies your program
▶ A consistent nonclinical and clinical data
package that sets you up for success
PARTNERSHIP
Achieve your Target Product Profile,
with deep drug development
and regulatory expertise
VALUE
Spend less time managing contracts
and more time driving your business
▶ Gain deep insight from nonclinical, clinical, regulatory and health economics advisors
▶ De-risk your molecule development and maximize the value of your asset
▶ Access to therapeutic expertise in diabetes, oncology, cardiology and more
▶ Delivery of critical milestone dates
▶ Flexible contracting to de-risk your
development program
▶ Right billing strategy that fits your
business model
ACCELERATE THE SUCCESS OF YOUR DRUG DEVELOPMENT JOURNEY.
CALL TO LEARN MORE ABOUT EARLY PHASE DEVELOPMENT SOLUTIONS.
The Americas +1.888.COVANCE | Europe/Africa +00.800.2682.2682
Asia Pacific +800.6568.3000 | Or go to covance.com/epds
Covance Inc., headquartered in Princeton, NJ, is the drug development business of Laboratory Corporation of America® Holdings (LabCorp®).
Covance is the marketing name for Covance Inc. and its subsidiaries around the world.
© Copyright 2017. Covance Inc. SSCVD007-0617